Frank W. Chan's most recent trade in Haemonetics Corp. was a trade of 27,535 Common Stock done . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Haemonetics Corp | Frank W. Chan | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 27,535 | 32,936 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp | Frank W. Chan | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.29 per share. | 15 May 2026 | 546 | 5,401 (0%) | 0% | 56.3 | 30,734 | Common Stock |
| Haemonetics Corp | Frank W. Chan | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 12,317 | 12,317 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp | Frank W. Chan | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 5,689 | 5,689 (0%) | 0% | - | Common Stock |